(Q38098467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Therapeutic potential of regulatory T cells in autoimmune disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Johannes Fessler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Anja Felber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Christina Duftner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

281-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

Autoreactive T cells in healthy individuals

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Imbalance of regulatory T cells in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Helios expression is a marker of T cell activation and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

"Infectious" transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CTLA-4 ligation blocks CD28-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Decreased FOXP3 levels in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

IL-17-producing human peripheral regulatory T cells retain suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Epigenetic mechanisms of regulation of Foxp3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Infliximab reduces the frequency of interleukin 17-producing cells and the amounts of interleukin 17 in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

OX40 costimulation turns off Foxp3+ Tregs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Regulatory activity of autocrine IL-10 on dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Epigenetic control of the foxp3 locus in regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Activation requirements for the induction of CD4+CD25+ T cell suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-013-0026-5

10.1007/S40259-013-0026-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23580095%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference